Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Advent International Corp.

BioCentury | Dec 4, 2021
Product Development

Dec. 3 Quick Takes: Recordati buying EUSA

Plus Sobi, BMS, Valneva, Sylvant and more
BioCentury | Aug 27, 2021
Deals

Aug. 26 Quick Takes: Bolt, Innovent partner on non-traditional antibody conjugates

Plus ADC royalty deal, Sobi, Servier, DiCE IPO plans, AZ in Wilson’s and more
BioCentury | Apr 20, 2018
Company News

Advent to acquire Sanofi's EU generics business

BioCentury | Jun 28, 2010
Financial News

Nereus completes venture financing

BioCentury | Feb 18, 2008
Company News

Hunter-Fleming, Newron deal

BioCentury | Jul 31, 2000
Company News

Enanta board of directors update

BioCentury | Jul 3, 2000
Company News

Anadys board of directors update

Items per page:
1 - 10 of 11